Oliver Peters
← Back to Freie Universität Berlin
Freie Universität Berlin
Oliver Peters works in Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Cancer-related cognitive impairment studies, Neuroinflammation and Neurodegeneration Mechanisms, Functional Brain Connectivity Studies. Recorded institutional associations include German Center for Neurodegenerative Diseases, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
2019 · 2,925 citationsNew insights into the genetic etiology of Alzheimer’s disease and related dementias
2022 · 2,462 citationsPrevalence of Cerebral Amyloid Pathology in Persons Without Dementia
2015 · 1,606 citationsRare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
2017 · 1,006 citationsAn unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
2012 · 776 citationsIdentification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood
2015 · 639 citationsGenetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
2010 · 606 citationsCerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
2011 · 591 citationsInhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
2012 · 415 citationsPrevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
2015 · 381 citationsCommon variants in Alzheimer’s disease and risk stratification by polygenic risk scores
2021 · 322 citationsIncreased Formation of Reactive Oxygen Species after Permanent and Reversible Middle Cerebral Artery Occlusion in the Rat
1998 · 298 citationsPrevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
2022 · 289 citationsProteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
2020 · 286 citationsAmyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 load
2006 · 263 citationsDesign and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
2018 · 232 citationsPlasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
2024 · 212 citationsSafety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
2022 · 202 citationsDifferent Mechanisms Promote Astrocyte Ca2+Waves and Spreading Depression in the Mouse Neocortex
2003 · 200 citationsAnti-amyloid antibody therapies in Alzheimer’s disease
2023 · 180 citationsCortical Spreading Depression Induces Proinflammatory Cytokine Gene Expression in the Rat Brain
2001 · 178 citationsBiomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
2012 · 174 citationsCerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type
2014 · 169 citationsSoluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
2008 · 161 citationsMediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age
2021 · 152 citations